Modus Operandi

» microbiology, techniques, immunology and virology

Most Recent

image: Custom-Made Molecules

Custom-Made Molecules

By | August 21, 2017

A new prototype machine can make the biological molecules of one’s choice from digital DNA sequences.

0 Comments

image: Microbiota Manipulations

Microbiota Manipulations

By | July 17, 2017

Two research teams develop tools for tinkering with a bacterial genus prominent in human guts.

0 Comments

These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.

0 Comments

image: Phosphorylation at the Flick of a Switch

Phosphorylation at the Flick of a Switch

By | May 1, 2017

Incorporating light-controlled dimerization domains into kinases provides tight regulation of these enzymes.

0 Comments

image: Targeting Tregs Halts Cancer’s Immune Helpers

Targeting Tregs Halts Cancer’s Immune Helpers

By | April 1, 2017

New monoclonal antibodies kill both cancer-promoting immunosuppressive cells and tumor cells in culture.

0 Comments

image: Massively Parallel Perturbations

Massively Parallel Perturbations

By | March 1, 2017

Scientists combine CRISPR gene editing with single-cell sequencing for genotype-phenotype screens.

0 Comments

image: Deep Pocket Exploration

Deep Pocket Exploration

By | February 1, 2017

A modification to traditional docking software enables the examination of a ligand’s passage into its receptor.

0 Comments

A test tube-based genome-labeling technique has been brought under the microscope.

0 Comments

image: Synthetic Sensors

Synthetic Sensors

By | December 1, 2016

Engineered circuits detect endogenous transcription factors to drive cellular outputs.

0 Comments

image: Neural Connectome Method Uses mRNA Barcodes

Neural Connectome Method Uses mRNA Barcodes

By | November 1, 2016

Researchers swap microscopy for RNA sequencing to track neural paths in the mouse brain.  

0 Comments

Popular Now

  1. How Animals and Plants Weather Hurricanes
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech